QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 8 April 2004
doi: 10.1242/dev.01053

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: dev.01053v1 131/9/2161    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zelzer, E. Articles by Olsen, B. R. Search for Related Content PubMed PubMed Citation Articles by Zelzer, E. Articles by Olsen, B. R. Social Bookmarking                         What's this?

VEGFA is necessary for chondrocyte survival during bone development

¹ Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA
² Department of Surgical Research, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA
³ Department of Molecular Oncology, Genentech, South San Francisco, CA 94080, USA
⁴ Molecular Biology Section, Division of Biology, University of California, San Diego, CA 92093, USA
⁵ Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA

^* Author for correspondence (e-mail: bjorn_olsen{at}hms.harvard.edu)

Accepted 30 December 2003

To directly examine the role of vascular endothelial growth factor (VEGFA) in cartilage development, we conditionally knocked out Vegfa in chondrocytes, using the Col2a1 promoter to drive expression of Cre recombinase. Our study of Vegfa conditional knockout (CKO) mice provides new in-vivo evidence for two important functions of VEGFA in bone formation. First, VEGFA plays a significant role in both early and late stages of cartilage vascularization, since Vegfa CKO mice showed delayed invasion of blood vessels into primary ossification centers and delayed removal of terminal hypertrophic chondrocytes. Second, VEGFA is crucial for chondrocyte survival, since massive cell death was seen in joint and epiphyseal regions of Vegfa CKO endochondral bones. Chondrocytes in these regions were found to upregulate expression of Vegfa in wild-type mice at the time when massive cell death occurred in the Vegfa CKO mice. The expression of the VEGFA receptors Npr1 and Npr2 in epiphyseal chondrocytes and lack of blood vessel reduction in the vicinity of the cartilaginous elements in the Vegfa CKO mice raise the possibility that the observed cell death is the result of a direct involvement of VEGFA in chondrocyte survival. Interestingly, the extensive cell death seen in Vegfa CKO null bones had a striking similarity to the cell death phenotype observed when hypoxia-inducible factor 1 (Hif1a) expression was abolished in developing cartilage. This similarity of cell death phenotypes and the deficient VEGFA production in Hif1a null epiphyseal chondrocytes demonstrate that HIF1 and VEGFA are components of a key pathway to support chondrocyte survival during embryonic bone development.

Key words: Conditional knockout mice, VEGFA, Chondrocyte survival, Bone development, Angiogenesis, HIF1, HIF1, VEGF

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. L. Hammond and S. Schulte-Merker Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling Development, December 1, 2009; 136(23): 3991 - 4000. [Abstract] [Full Text] [PDF]

				I. Eshkar-Oren, S. V. Viukov, S. Salameh, S. Krief, C.-d. Oh, H. Akiyama, H.-P. Gerber, N. Ferrara, and E. Zelzer The forming limb skeleton serves as a signaling center for limb vasculature patterning via regulation of Vegf Development, April 15, 2009; 136(8): 1263 - 1272. [Abstract] [Full Text] [PDF]

				A. R. Cuddihy, S. Ge, J. Zhu, J. Jang, A. Chidgey, G. Thurston, R. Boyd, and G. M. Crooks VEGF-mediated cross-talk within the neonatal murine thymus Blood, March 19, 2009; 113(12): 2723 - 2731. [Abstract] [Full Text] [PDF]

				G. Yang, Q. Sun, Y. Teng, F. Li, T. Weng, and X. Yang PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1{alpha} signaling and endoplasmic reticulum stress Development, November 1, 2008; 135(21): 3587 - 3597. [Abstract] [Full Text] [PDF]

				Y. Shinoda, N. Ogata, A. Higashikawa, I. Manabe, T. Shindo, T. Yamada, F. Kugimiya, T. Ikeda, N. Kawamura, Y. Kawasaki, et al. Kruppel-like Factor 5 Causes Cartilage Degradation through Transactivation of Matrix Metalloproteinase 9 J. Biol. Chem., September 5, 2008; 283(36): 24682 - 24689. [Abstract] [Full Text] [PDF]

				E. Schipani and T. L. Clemens Hypoxia and the Hypoxia-Inducible Factors in the Skeleton IBMS BoneKEy, August 1, 2008; 5(8): 275 - 284. [Abstract] [Full Text] [PDF]

				K. K. VanKoevering and B. O. Williams Transgenic Mouse Strains for Conditional Gene Deletion During Skeletal Development IBMS BoneKEy, May 1, 2008; 5(5): 151 - 170. [Abstract] [Full Text] [PDF]

				M. Chen, M. Zhu, H. Awad, T.-F. Li, T.-J. Sheu, B. F. Boyce, D. Chen, and R. J. O'Keefe Inhibition of {beta}-catenin signaling causes defects in postnatal cartilage development J. Cell Sci., May 1, 2008; 121(9): 1455 - 1465. [Abstract] [Full Text] [PDF]

				J. Dai and A.B.M. Rabie VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification Journal of Dental Research, October 1, 2007; 86(10): 937 - 950. [Abstract] [Full Text] [PDF]

				S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H. M. Kronenberg, R. S. Johnson, M. T. Longaker, A. J. Giaccia, and E. Schipani Hif-1{alpha} regulates differentiation of limb bud mesenchyme and joint development J. Cell Biol., May 7, 2007; 177(3): 451 - 464. [Abstract] [Full Text] [PDF]

				K. K. Mak, M.-H. Chen, T. F. Day, P.-T. Chuang, and Y. Yang Wnt/{beta}-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation Development, September 15, 2006; 133(18): 3695 - 3707. [Abstract] [Full Text] [PDF]

				R. D. Ward, B. M. Stone, L. T. Raetzman, and S. A. Camper Cell Proliferation and Vascularization in Mouse Models of Pituitary Hormone Deficiency Mol. Endocrinol., June 1, 2006; 20(6): 1378 - 1390. [Abstract] [Full Text] [PDF]

				Y. Macotela, M. B. Aguilar, J. Guzman-Morales, J. C. Rivera, C. Zermeno, F. Lopez-Barrera, G. Nava, C. Lavalle, G. M. de la Escalera, and C. Clapp Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin J. Cell Sci., May 1, 2006; 119(9): 1790 - 1800. [Abstract] [Full Text] [PDF]

				S. R. Wedge, J. Kendrew, L. F. Hennequin, P. J. Valentine, S. T. Barry, S. R. Brave, N. R. Smith, N. H. James, M. Dukes, J. O. Curwen, et al. AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer Cancer Res., May 15, 2005; 65(10): 4389 - 4400. [Abstract] [Full Text] [PDF]

				M. Korc Targeted Therapeutics in Pancreatic Cancer: A Ray of Hope Clin. Cancer Res., January 1, 2005; 11(1): 410 - 411. [Full Text] [PDF]

				D. Stickens, D. J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A. J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb Altered endochondral bone development in matrix metalloproteinase 13-deficient mice Development, December 1, 2004; 131(23): 5883 - 5895. [Abstract] [Full Text] [PDF]

				D. Pfander, T. Kobayashi, M. C. Knight, E. Zelzer, D. A. Chan, B. R. Olsen, A. J. Giaccia, R. S. Johnson, V. H. Haase, and E. Schipani Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development Development, May 15, 2004; 131(10): 2497 - 2508. [Abstract] [Full Text] [PDF]